Journal of Public Health Medicine 21:439-446 (1999)
© 1999 Faculty of Public Health Medicine of the Royal Colleges of Physicians of the United Kingdom
Guidance for control of parvovirus B19 infection in healthcare settings and the community
NS Crowcroft0,z
CE Roth0
BJ Cohen1
E Miller0
0 Immunisation Division, Public Health Laboratory Service (PHLS), Communicable Disease Surveillance Centre (CDSC), 61 Colindale Avenue, London NW9 5EQ, UK
1 Enteric and Respiratory Virus Laboratory, PHLS Central Public Health Laboratory (CPHL), 61 Colindale Avenue, London NW9 5HT, UK
z Corresponding author
Interventions for parvovirus B19 infection need to balance the low risk of infection at a population level with the potential for serious adverse outcome for particular groups, notably the fetus, people with haemoglobinopathies and the immunocompromised. This guidance aims to assist the local decision-making process to be as evidence-based as the available evidence allows.
Keywords: human parvovirus B19, infectious pregnancy complications, erythema infectiosum, infection control
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Xu, T. C. Raff, N. S. Muallem, and A. G. Neubert Hydrops Fetalis Secondary to Parvovirus B19 Infections J Am Board Fam Med, January 1, 2003; 16(1): 63 - 68. [Abstract] [Full Text] [PDF] |
||||
